Effects of Labetalol on Hemodynamics and Seizure Duration During ECT

W. Vaughn McCall1, Frank E. Shelp, Richard D. Weiner

  • 1John Umstead Hospital, Butner, North Carolina, and Duke University Medical Center, Durham, North Carolina, USA.

Convulsive Therapy
|January 1, 1991
PubMed

Insights

Labetalol effectively reduces heart rate and rate pressure product during electroconvulsive therapy (ECT) in a dose-dependent manner. However, it did not significantly impact blood pressure or seizure duration in this study.

Area of Science:

  • Anesthesiology
  • Cardiology
  • Neurology

Background:

  • Beta blockers are frequently administered to manage heart rate and blood pressure surges during electroconvulsive therapy (ECT).
  • Concerns exist regarding potential anticonvulsant effects of some beta blockers, which might interfere with ECT efficacy.
  • Labetalol, a combined alpha and beta blocker, is commonly used in this context.

Purpose of the Study:

  • To investigate the dose-response relationship of intravenous labetalol on hemodynamic responses and seizure duration during ECT.
  • To evaluate the potential countertherapeutic effects of labetalol in ECT.

Main Methods:

  • A randomized, double-blind, placebo-controlled study was conducted.
  • Participants received varying doses of intravenous labetalol (5 mg, 10 mg) or placebo prior to ECT.
  • Hemodynamic parameters (heart rate, blood pressure, rate pressure product) and seizure duration were monitored.

Main Results:

  • Labetalol demonstrated a dose-dependent reduction in heart rate and rate pressure product at 5 mg and 10 mg compared to placebo.
  • No significant differences in blood pressure or seizure duration were observed between labetalol groups and the placebo group.
  • The 5 mg and 10 mg doses of labetalol did not show significant differences in their effects on the measured parameters.

Conclusions:

  • Intravenous labetalol effectively attenuates heart rate and rate pressure product during ECT in a dose-dependent manner.
  • Labetalol does not appear to significantly affect blood pressure or seizure duration in the tested dosage range.
  • These findings suggest labetalol can be safely used for hemodynamic management during ECT without compromising seizure efficacy.

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Electrocardiogram01:29

Electrocardiogram

An electrocardiogram (ECG or EKG) is a critical diagnostic tool that records the electrical signals produced by the heart during each heartbeat. This recording is achieved through electrodes placed strategically on the arms, legs, and chest. The electrocardiograph amplifies these signals and produces 12 distinct tracings, offering a comprehensive understanding of the heart's electrical activity.
Three major waveforms are present in a typical ECG recording: the P wave, the QRS complex, and the T...
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
Electroconvulsive Therapy01:30

Electroconvulsive Therapy

Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early years,...
Seizures l: Introduction01:20

Seizures l: Introduction

Understanding seizures and epilepsy relies on key definitions that help in recognizing, classifying, and managing these disorders. These definitions provide a framework for recognizing, classifying, and managing seizure disorders.DefinitionsA seizure is a sudden, abnormal burst of electrical activity in the brain that can cause changes in awareness, movement, sensation, or behavior, depending on the area involved. Epilepsy is a chronic condition characterized by recurrent, unprovoked seizures,...